(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | 42.13%290.55M | 31.59%463.88M | 26.14%204.42M | 65.72%352.51M | --162.07M | 139.76%212.71M | --88.72M |
Operating income | 42.13%290.55M | 31.59%463.88M | 26.14%204.42M | 65.72%352.51M | 162.07M | 139.76%212.71M | 88.72M |
Cost of sales | -54.70%-141.6M | -34.98%-206.77M | -32.67%-91.53M | -65.23%-153.19M | ---68.99M | -131.95%-92.71M | ---39.97M |
Operating expenses | -54.70%-141.6M | -34.98%-206.77M | -32.67%-91.53M | -65.23%-153.19M | -68.99M | -131.95%-92.71M | -39.97M |
Gross profit | 31.94%148.96M | 28.99%257.11M | 21.29%112.9M | 66.10%199.32M | 93.08M | 146.16%120M | 48.75M |
Selling expenses | -3.14%-2.96M | -81.65%-6.5M | -91.33%-2.87M | -102.03%-3.58M | ---1.5M | -124.02%-1.77M | ---791K |
Administrative expenses | -56.81%-18.26M | -17.79%-26.13M | -9.92%-11.64M | -60.04%-22.18M | ---10.59M | -295.44%-13.86M | ---3.51M |
Research and development expenses | -23.34%-70.81M | -40.37%-119.15M | -46.16%-57.41M | -78.28%-84.88M | ---39.28M | -67.61%-47.61M | ---28.41M |
Impairment and provision | -436.23%-3.52M | ---- | --1.05M | ---- | ---- | ---- | ---- |
-Other impairment is provision | -436.23%-3.52M | ---- | --1.05M | ---- | ---- | ---- | ---- |
Special items of operating profit | 202.76%17.08M | -17.35%8.09M | 238.25%5.64M | 139.56%9.79M | --1.67M | 107.99%4.09M | --1.97M |
Operating profit | 47.91%70.5M | 15.18%113.43M | 9.88%47.66M | 61.84%98.48M | 43.37M | 237.79%60.85M | 18.01M |
Financing cost | -88.20%-3.38M | -158.57%-4.27M | -193.46%-1.8M | 57.42%-1.65M | ---612K | 3.51%-3.88M | ---4.02M |
Earning before tax | 46.34%67.12M | 12.74%109.16M | 7.26%45.86M | 69.96%96.82M | 42.76M | 307.07%56.97M | 14M |
Tax | ---- | ---- | ---- | ---1.56M | ---- | ---- | ---- |
After-tax profit from continuing operations | 46.34%67.12M | 14.59%109.16M | 7.26%45.86M | 67.22%95.26M | 42.76M | 307.07%56.97M | 14M |
Earning after tax | 46.34%67.12M | 14.59%109.16M | 7.26%45.86M | 67.22%95.26M | 42.76M | 307.07%56.97M | 14M |
Profit attributable to shareholders | 46.34%67.12M | 14.59%109.16M | 7.26%45.86M | 67.22%95.26M | 42.76M | 307.07%56.97M | 14M |
Basic earnings per share | 9.80%1.12 | 14.15%2.42 | 1.02 | 2.12 | |||
Diluted earnings per share | 9.80%1.12 | 14.15%2.42 | 1.02 | 2.12 | |||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data